Oklahoma Association of Nurse Practitioners 18th Annual ... · Oklahoma Association of Nurse...
Transcript of Oklahoma Association of Nurse Practitioners 18th Annual ... · Oklahoma Association of Nurse...
Oklahoma Association of Nurse Practitioners
18th Annual Meeting Program Directory
Sheraton - Reed Center 5800 Will Rogers
Midwest City, OK 73110
2
October 17-19, 2012
Welcome!
Dear Fellow NP Professionals,
We are delighted that you have chosen to join us for the 18th Annual Oklahoma Nurse Practitioners Conference.
This is a great opportunity to, not only attend a fantastic conference, but rekindle old friendships, create new networking opportunities and take in the constantly evolving sites around Oklahoma City. Furthering your knowledge of the latest treatment techniques, through informative lectures on the latest studies and practices and hands-‐on exhibits, will renew your sense of purpose and further your commitment to the profession.
Take advantage of what the next few days have to offer and make the most of your meeting. We’re glad you’re here.
Sincerely,
Bronwyn Dianne Bronwyn Howard Dianne Miller-‐Boyle ONP President President-‐elect, ONP Conference Chair
3
PURPOSE The ONP Conference is to provide a variety of educational topics to develop the maximal effectiveness of APRNs in their roles as healthcare providers in diverse settings across Oklahoma.
GOALS 1. Provide an organized learning experience that augments the knowledge and skills of
the APRN in various settings.
2. Serve as a forum where research pertinent to the specialty of nurse practitioners can be presented.
4. Familiarize the nurse practitioner with the latest medical equipment, technology, and pharmacological products.
3. Provide ONP members with an opportunity to participate in the business of the ONP.
4. Facilitate interaction and networking between participants on a professional and social level.
NEEDS ASSESSMENT AND TARGET AUDIENCE The ONP Conference Committee has reviewed program evaluations and other feedback from the ONP members to identify the issues that affect nurse practitioner practice. The topics are determined based on overall member surveys, national trends and issues, and gaps in knowledge to further develop the professional practice of APRNs. The education activities were developed to meet the needs of APRNs, nurse practitioner students, and other healthcare providers with an interest in the topics.
ACCREDITATION STATEMENTS The 18th ONP Annual Conference has been planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards. The 2012 ONP Conference is approved for continuing education by the American Academy of Nurse Practitioners. This program is approved for 14.25 contact hours of continuing education (which includes 7.5 hours of pharmacology) by the American Academy of Nurse Practitioners. Program ID 1209337. We also have approval for 15.6 hours from the Oklahoma Board of Nursing.
REQUIREMENT FOR EARNING CONTINUING EDUCATION CE credit will be given only for those lectures and educational activities that participants attend in their entirety.
In 2012 – ONP continues our efforts to GO GREEN. The CE Certificates are now digitally created and emailed to you. Please make sure to have your name badge scanned at the start of each session to record your attendance. This record will be used to create your CE Certificate. Your CE Certificate will be emailed to you after the conference.
4
ONLINE SESSION AND CONFERENCE EVALUATIONS The Conference and individual session evaluations have been The educational session evaluations are important feed-‐ back for the ONP Program Committee and the presenters. This information is helpful in developing future programs. All participants are requested to complete evaluations for all the sessions they attended.
All evaluations can be filled out using our easy online forms at http://www.npofoklahoma.com/activities. All evaluations are anonymous -‐ evaluate each speaker and session carefully and completely for each session you have attended.
CE RECORD ONP continues to evolve our continuing education sessions into more environmentally friendly and streamlined Conferences. Attendees no longer fill out paper CE records or session evaluations; the process will be entirely electronic.
Your badge is equipped with an individualized QR code with your name, license number and email address. You must have your badge scanned before entering each lecture you attend. The scan will record your attendance for each lecture. The corresponding credits will automatically be transferred to a document that will be e-‐mailed to you at the end of the ONP Conference.
It is imperative therefore that all attendees wear and scan their badges for the duration of the meeting. There will be a $10 charge for replacement badges. Please talk to ONP Executive Director, Benny Vanatta, or Cathey Jo, at the conference help desk, if you have any questions or encounter any difficulties with our new CE procedures. We want to ensure you continue to have a positive and rewarding meeting experience as we implement new technology to better serve you.
5
OVERVIEW OF EDUCATIONAL SESSIONS AND EVENTS
WEDNESDAY, OCTOBER 17, 2012
5:30-6:00 pm Dinner Buffet Open
6:00-7:30 pm Cardiomyopathy Across the Lifespan Speakers: Teresa Whited, MS, APRN, CNP, CPNP-PC Vonnie Rodgers, APRN, CNP, ANP
7:40-8:40 pm Initiating Treatment for DM2 Patients in an Emergency/Urgent Care Setting Speaker: Donna Blach, APRN, CNP, DNP
8:40-9:10 pm
ONP PAC Meeting: Let’s Talk About Getting to Grassroots! Speakers: Benny Vanatta, ONP Executive Director Mindy Whitten, ONP Legislative Chair (Optional activity for participants interested in legislative activity related to the NP profession - no CE.)
THURSDAY, OCTOBER 18, 2012
You will have an opportunity to visit exhibitors during break periods.
6:45-7:00 am Breakfast Buffet Open
7:00-8:00 am The Unmentionables: Bladders, Vaginas, and Rectums (Breakfast/Lecture) Mikio Nihira, MD, MPH
8:15-9:30 am Federal Legislative Update Speaker: Janet Selway, DNSc, ANP-BC, CPNP
9:35-10:35 am Hepatitis C Update Speaker: Teddy Bader, MD
10:35-11:15 am Break
11:15-12:30 pm ONP Annual Business Meeting
12:30-1:30 pm
(Lunch/Lecture) Introducing ZETONNA (ciclesonide) Nasal Aerosol: A New Dry Option for Allergic Rhinitis (no CE credit) Speaker: Martha M. Tarpay, MD Sponsored by Sunovion Pharmaceuticals
1:30-2:00 pm Break
2:00-3:30 pm Recognition, Evaluation, and Management of PTSD in Our Returning Veterans Speaker: Andrea Gonterman, PhD, and Peggy Jewell, MD
6
DETAILED LISTING OF CONFERENCE SESSIONS AND EVENTS Wednesday, October 17, 2012
Cardiomyopathy Across the Lifespan 6:00 pm -‐ 7:30 pm
Speakers: Teresa Whited, MS, APRN, CNP, CPNP-‐PC, and Vonnie Rodgers, APRN, CNP, ANP About the Speaker: Teresa Whited received her Bachelors Degree in Nursing in 1999 and her Masters Degree in 2003, as a Nurse Practitioner at the University of Oklahoma. After Certification as a Pediatric Nurse Practitioner, she began a career in Pediatric Cardiology and has continued to work there as a Nurse Practitioner for the past nine years. She serves as faculty in the
3:40-4:40 pm Providing Primary Care for the Post-Transplant Patient Speaker: Dorothy Belknap, APRN, CNP, PhD
4:50-5:50 pm Treatment of Alzheimer’s Disease and Related Dementias Speaker: Deb Greubel, APRN, CNP, DNP
6:00-7:00 pm Safe Prescribing Practices for Nurse Practitioners Speaker: Mindy Whitten, APRN, CNP, DNP
7:00 pm - Dinner on your own
FRIDAY, OCTOBER 19, 2012
You will have an opportunity to visit exhibitors during break periods.
7:00 -7:30 am Breakfast Buffet Open
7:30-8:30 am Hematuria and Abnormal PSAs Speaker: Steven Archer, MD
8:45-10:15 am Dangerous Liaisons: Drug-drug, Drug-nutrient Interactions Speaker: Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC
10:30-12:00 pm Antimicrobial Update: A focus on Prescribing in the Era of Resistant Pathogens Speaker: Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC
ADJOURNMENT: Don’t forget to complete the online evaluations!
7
University of Oklahoma Nurse Practitioner program as well as Coordinator of the Pediatric Nurse Practitioner Track. Program objectives: Learn to identify key pathophysiologic features and contributing factors to the severity of cardiac conditions in children and adults. Learn key assessment components of subjective/history signs and symptoms for cardiac conditions in children and adults. Learn key assessment components of the physical examination for cardiac conditions in children and adults. Recognize common diagnostic and monitoring methods for cardiac conditions in children and adults. Discuss non-‐pharmacologic management of cardiac conditions in children and adults. Individualize pharmacotherapeutic management to patient’s specific age, needs, and co-‐morbidities. Identify components of evaluation, follow-‐up, and potential complications of cardiac conditions in children and adults. Discuss case studies of cardiac conditions in children and adults. Contact hours for this session: AANP pharm hours = 0.58 hr AANP CE = 1.5 hr BON pharm hours = 1.8 hr
Initiating Treatment for DM2 Patients in an Emergency/Urgent Care Setting 7:40pm -‐ 8:40 pm
Speaker: Donna Blach, APRN, CNP, DNP About the Speaker: Has worked in various emergency departments since 1999, at the Veterans Administration ED from 2008 to present, and in the Fellow’s Diabetic Clinic starting in 2012. Developed a model for working with diabetic patients in the ED during my DNP program.
Session Objectives: Identify key pathophysiologic features and contributing factors to the severity of diabetes mellitus type 2 in an emergent/urgent care setting. Describe key assessment components of subjective/history signs and symptoms of diabetes mellitus type 2 in an emergent/urgent care setting. Describe key assessment components of the physical examination for diabetes mellitus type 2 in an emergent/urgent care setting. Recognize common diagnostic and monitoring methods diabetes for mellitus type 2 in an emergent/urgent care setting. Discuss non-‐pharmacologic management of diabetes mellitus type 2 in an emergent/urgent care setting. Individualize pharmacotherapeutic management to patient’s specific needs and co-‐morbidities in the emergent/urgent care setting. Explore rationale for differences between pharmacotherapeutic treatment in primary care and emergent/urgent care treatment of diabetes mellitus type 2. Discuss case studies of hyperglycemic conditions.
8
Contact hours for this session: AANP pharm hours = 0.42 hr AANP CE = 1.0 hr BON pharm hours = 1.2 hr
ONP PAC Meeting: Let’s Talk About Getting to Grassroots! 8:40pm -‐ 9:10 pm
Speakers: Benny Vanatta, ONP Executive Director, and Mindy Whitten, ONP Legislative Chair Objectives and contact hours for this session: (Optional activity for participants interested in legislative activity related to the NP profession -‐ no CE.)
Thursday, October 18, 2012
6:45 am – 7:00 am Breakfast Buffet is open The Unmentionables: Bladders, Vaginas, and Rectums 7:00 am -‐ 8:00 am breakfast/presentation
Speaker: Mikio Nihira, MD, MPH About the Speaker: Diplomate with the American Board of Obstetrics & Gynecology, Fellow of the American College of Surgeons, 22 Peer-‐reviewed publications, 14 years of post-‐graduate experience. Session Objectives: Identify key pathophysiologic features and contributing factors to the severity of urinary incontinence, fecal incontinence. Describe key assessment components of subjective/history signs and symptoms of urinary incontinence, fecal incontinence. Describe key assessment components of the physical examination for urinary incontinence, fecal incontinence. Recognize common diagnostic and monitoring methods of urinary incontinence, fecal incontinence. Distinguish symptoms of pelvic heaviness from pelvic organ prolapse. List indications for referral to a urogynecologist. Identify the different salvage treatments for urge urinary incontinence. Recognize new treatments for fecal incontinence. Individualize pharmacotherapeutic management to patient’s specific age, needs and co-‐morbidities. Identify components of evaluation, follow-‐up, and potential complications of urinary incontinence, fecal incontinence treatments. Discuss case studies, questions/answers for urinary incontinence, fecal incontinence.
9
Contact hours for this session: AANP pharm hours = 0.25 hr AANP CE = 1.0 BON pharm hours = 1.2 hr
Federal Legislative Update 8:15 am -‐ 9:30 am
Speaker: Janet Selway, DNSc, ANP-‐BC, CPNP
About the Speaker: 2011 ACNP President-‐ Fulltime National NP Advocacy Organization, 2010 ACNP President Elect. Works with the CEO, Health Policy Director and Government Relations Director to participate in decisions regarding federal legislative issues impacting the nation’s health and nurse practitioner practice. Janet has been elected to the ACNP Board of Directors four times since its inception.
Session Objectives: Describe ACNP’s 2012 health policy agenda. Describe general overview and anticipated benefits of proposed consolidation of AANP and ACNP. Discuss Democratic and Republican health platforms and the impact this may have on NP practice. Describe at least 3 key concepts regarding ACOs and Health Insurance Exchanges. Summarize major bills concerning NP practice. Discuss grassroots lobbying tips. Contact hours for this session: AANP pharm hours = 0 hr AANP CE = 1.25 BON pharm hours = 1.8 hr
Hepatitis C Update 9:35 am -‐ 10:35 am
Speaker: Teddy Bader, MD
About the Speaker: Gastroenterologist/Hepatologist at Kaiser permanente 1988-‐2002, Oklahoma Transplantation Institute 2002-‐2005, Professor of Medicine at OUHSC College of Medicine Dept of Medicine/Gastroenterology 2005-‐present, Director of Liver Diseases OUHSC 2007-‐present. Session Objectives: Discuss 3 main concerns of hepatitis C patients. Discuss sexual and other forms of transmission. Discuss natural history of hepatitis C. Discuss that hepatitis C is curable: pharmacotherapeutics. Provide a summary of current pharmacologic treatment protocols for hepatitis C. Contact hours for this session: AANP pharm hours = 0.59 hr
10
AANP CE = 1.0 hr BON pharm hours = 1.2 hr
Opportunity to visit Exhibitors 10:35 am -‐ 11:15 am
ONP Annual Business Meeting 11:15 am – 12:30 pm
Lunch Lecture: Introducing ZETONNA (ciclesonide) Nasal Aerosol: A New Dry Option for Allergic Rhinitis 12:30 pm -‐ 1:30 pm
Speaker: Martha M. Tarpay, MD
Contact hours for this session: There are no CE Contact hours for this lunch lecture. Lunch Lecture is SPONSORED BY SUNOVION PHARMACEUTICALS
Opportunity to visit Exhibitors 1:30 pm -‐ 2:00 pm
Recognition, Evaluation, and Management of PTSD in Our Returning Veterans 2:00 pm -‐ 3:30 pm
Speaker: Andrea Gonterman, PhD, and Peggy Jewell, MD About the Speaker: Andrea Gonterman conducts group and individual therapy for veterans diagnosed with PTSD. Groups conducted include Cognitive Processing Therapy (CPT-‐C), an evidence-‐based treatment modality, trauma recounting groups, and post-‐treatment support. Individual therapy conducted utilizing Prolonged Exposure Therapy (PE) or Cognitive Processing Therapy (CPT or CPT-‐C), both evidence-‐based treatment modalities.
Peggy Jewell is currently medical director for Post Traumatic Stress Disorder Treatment Program at the VA Medical Center in Oklahoma City, Oklahoma. Other training includes Cognitive Processing Therapy for Post Traumatic Stress Disorder Training at the VAMC of the Ozarks and Post Traumatic Stress Disorder Training at the National Center for Post Traumatic Stress Disorder.
Session Objectives: Identify key pathophysiologic features and contributing factors to the severity of PTSD. (1) Describe key assessment components of
11
subjective/history signs and symptoms of PTSD. (1) Describe key assessment components of the physical/mental examination for PTSD. (1) Recognize common diagnostic and monitoring methods for PTSD. (1) Discuss non-‐pharmacologic management of PTSD. (1) Individualize pharmacotherapeutic management to patient’s specific age, needs, and co-‐morbidities. (2) Identify components of evaluation, follow-‐up, and potential complications of PTSD. (1 and 2). Discuss case studies of PTSD. (1and 2) Contact hours for this session: AANP pharm hours = 0.54 hr AANP CE = 1.5 hr BON pharm hours = 1.8 hr
Providing Primary Care for the Post-‐Transplant Patient 3:40 pm -‐ 4:40 pm
Speaker: Dorothy Belknap, APRN, CNP, PhD About the Speaker: BSN, MA, M.Ed, PhD. Veterans Administration Medical Center Nurse Practitioner position in Ambulatory Care Clinics; Transplant Coordinator in Transplant Service 2004 to present; Inpatient Hospitalist Service 2005 to 2012.
Session Objectives: Describe the collaborative relationship between the primary care provider and transplant center in managing post-‐transplant health care. Understand principles of transplant immunology and potential for rejection. Discuss immunosuppression drug therapy, including action, adverse effects, and drug interactions. Describe specific diagnostic and monitoring methods recommended when providing primary care for the post-‐transplant patient. Discuss diagnosis and management of common long-‐term complications for post-‐solid organ transplant patients. Individualize pharmacotherapeutic management to patients’ specific needs and co-‐morbidities. Discuss non-‐pharmacologic management considerations when providing primary care for the post-‐transplant patient. Discuss case studies regarding providing primary care for post-‐transplant patients. Contact hours for this session: AANP pharm hours = 0.45 hr AANP CE = 1.0 hr BON pharm hours = 1.2 hr
Treatment of Alzheimer’s Disease and Related Dementias 4:50 pm -‐ 5:50 pm
Speaker: Deb Greubel, DNP, APRN, CNP
12
About the Speaker: Currently serve as the Divisional Director of Quality Management, Medical Staff Services, Risk Management, and Regulatory Compliance for Hillcrest Health Systems which encompasses six hospitals in Northeast Oklahoma. In addition, maintains a clinical practice in adult medicine and geriatrics at Utica Park Clinic on the Hillcrest Medical Center Campus in Tulsa.
Session Objectives: Identify key pathophysiologic features and contributing factors to the severity of Alzheimer’s Disease and Related Dementias. Describe key assessment components of subjective/history signs and symptoms of Alzheimer’s Disease and Related Dementias. Describe key assessment components of the physical examination for Alzheimer’s Disease and Related Dementias. Recognize common diagnostic and monitoring methods of Alzheimer’s Disease and Related Dementias. Discuss non-‐pharmacologic management of Alzheimer’s Disease and Related Dementias. Individualize pharmacotherapeutic management to patient’s specific needs and co-‐morbidities. Identify components of evaluation, follow-‐up, and potential complications of Alzheimer’s Disease and Related Dementias. Discuss case studies of Alzheimer’s Disease and Related Dementias. Contact hours for this session: AANP pharm hours = 0.42 hr AANP CE = 1.0 hr BON pharm hours = 1.2 hr
Safe Prescribing Practices for Nurse Practitioners 6:00 pm -‐ 7:00 pm
Speaker: Mindy Whitten, DNP, APRN, CNP
About the Speaker: BSN, MS, DNP. Nurse Practitioner primary care provider in family practice clinics since 1997, adjunct faculty for the University of Oklahoma Nurse Practitioner program (Tulsa) since 1998; current legislative chair for ONP, and current AANP state representative for Oklahoma since 2009.
Session Objectives: Identify why safe prescribing is needed. Describe key elements to safe, appropriate prescribing. Describe a step approach to appropriate prescribing. Identify the key components that must be on the prescription for Oklahoma. Describe the supervision part of prescriptive authority in Oklahoma, rules for Oklahoma NP’s in prescribing. Discuss Opoid abuse/diversion in Oklahoma and the PMP program. Identify ways to safely monitor appropriate Opoid prescriptions in the clinic setting with a Controlled substance monitoring program.
Contact hours for this session: AANP pharm hours = 1.0 hr AANP CE = 1.0 hr BON pharm hours = 1.2 hr
13
Friday, October 19, 2012
7:00 am – 7:30 am Breakfast Buffet is open
Hematuria and Abnormal PSAs 7:30 am -‐ 8:30 am
Speaker: Steven Archer, MD About the Speaker: Solo urology practice 1986-‐1996, The Urology Group OKC 1996-‐2006, Urology Centers of OK Division of Surgical Specialists of OK 2007 – present. Certified American Board of Urology 1987, recertified 1995, 2006.
Session Objectives: Identify key pathophysiologic features and contributing factors to the severity of hematuria and abnormal PSA. Describe key assessment components of subjective/history signs and symptoms of hematuria and abnormal PSA. Describe key assessment components of the physical examination for hematuria and abnormal PSA. Recognize common diagnostic and monitoring methods for hematuria and abnormal PSA. Discuss non-‐pharmacologic management of hematuria and abnormal PSA. Individualize pharmacotherapeutic management to patient’s specific needs and co-‐morbidities. Identify components of evaluation, follow-‐up, and potential complications of hematuria and abnormal PSA. Discuss case studies of hematuria and abnormal PSA.
Contact hours for this session: AANP pharm hours = 0.25 hr AANP CE = 1.0 hr BON pharm hours = 1.2 hr
Dangerous Liaisons: Drug-‐drug, Drug-‐nutrient Interactions 8:45 am -‐ 10:15 am
Speaker: Margaret A. Fitzgerald, DNP, FNP-‐BC, NP-‐C, FAANP, CSP, FAAN, DCC
About the Speaker: Dr. Margaret A. Fitzgerald is the President and Principal Lecturer with Fitzgerald Health Education Associates, Inc. She’s in clinical practice at the Greater Lawrence (MA) Family Health Center. She’s the recipient of the NONPF Lifetime Achievement Award, the Sharp Cutting Edge Award and is Fellow of the AANP and the American Academy of Nursing as well as a Diplomate of Comprehensive. She’s a Professional Member of the National Speakers Association, the first NP to earn the Certified Speaking Professional designation and has spoken in 47 states and 9 countries. More than 60,000 NPs have used the Fitzgerald course to successfully prepare for certification.
14
Dr. Fitzgerald is an editorial board member for NP Journal and Prescriber’s Letter. She’s widely published with more than 100 items. Her book, NP Certification Examination and Practice Preparation received the American Journal of Nursing Book of the Year Award for APN and has been published in English and Korean.
Session Objectives: Identify mechanisms of common drug-‐drug, drug-‐nutrient interactions. • Cytochrome P450 (CYP450) role in drug metabolism and interactions • Chelation effect • Impact of common foods on drug absorption
Describe commonly encountered and potential hazardous drug-‐drug, drug-‐nutrient interactions. • CYP450 substrate, inducer, inhibitor • Role in substrate toxicity or potential ineffective levels • Chelation with common foods
Develop strategies to avoid the above-‐mentioned interactions. Avoiding common CYP450 interactions. Timing of medications to avoid chelation effect. Contact hours for this session: AANP pharm hours = 1.5 hr AANP CE = 1.5 hr BON pharm hours = 1.8 hr
~ CONCURRENT SESSIONS ~
Antimicrobial Update: A focus on Prescribing in the Era of Resistant Pathogens 10:30 am -‐ 12:00 pm
Speaker: Margaret A. Fitzgerald, DNP, FNP-‐BC, NP-‐C, FAANP, CSP, FAAN, DCC
Session Objectives: Recognize the factors that influence the development of resistant pathogens. • Antibiotic overuse • Antibiotic underdosing • Limited new antimicrobial pipeline Identify patient characteristics that increase the risk of infection with a resistant pathogen. • Recent systemic antimicrobial use • Comorbidity • Age
15
Develop a patient care plan which takes into account the above listed data as well as the latest treatment recommendations for the treatment of select bacterial infections. Using ABRS, UTI guidelines as a model
Contact hours for this session: AANP pharm hours = 1.5 hr AANP CE = 1.5 hr BON pharm hours = 1.8 hr
Adjournment 12:00 pm
DON’T FORGET TO FILL OUT THE QUICK AND EASY ONLINE EVALUATIONS! SIMPLY GO TO HTTP://WWW.NPOFOKLAHOMA.COM/ACTIVITIES TO AND COMPLETE EACH OF THE INDIVIDUAL SESSION EVALUATIONS AND OVERALL CONFERENCE EVALUATION ONLINE.